449 related articles for article (PubMed ID: 36790635)
21. [Associations Between Insulin Resistance Indexes and Hyperuricemia in Hypertensive Population].
Xiong F; Yu C; Zhu LJ; Wang T; Zhou W; Bao HH; Cheng XS
Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2023 Jun; 45(3):390-398. PubMed ID: 37407524
[TBL] [Abstract][Full Text] [Related]
22. Gamma-glutamyl transferase to high-density lipoprotein cholesterol ratio is a more powerful marker than TyG index for predicting metabolic syndrome in patients with type 2 diabetes mellitus.
Gong S; Gan S; Zhang Y; Zhou H; Zhou Q
Front Endocrinol (Lausanne); 2023; 14():1248614. PubMed ID: 37854188
[TBL] [Abstract][Full Text] [Related]
23. Comparison of different insulin resistance surrogates to predict hyperuricemia among U.S. non-diabetic adults.
Wang H; Zhang J; Pu Y; Qin S; Liu H; Tian Y; Tang Z
Front Endocrinol (Lausanne); 2022; 13():1028167. PubMed ID: 36589794
[TBL] [Abstract][Full Text] [Related]
24. Serum lipoprotein lipid profile in women with the polycystic ovary syndrome: relation to anthropometric, endocrine and metabolic variables.
Holte J; Bergh T; Berne C; Lithell H
Clin Endocrinol (Oxf); 1994 Oct; 41(4):463-71. PubMed ID: 7955457
[TBL] [Abstract][Full Text] [Related]
25. Non-insulin-based insulin resistance indexes in predicting severity for coronary artery disease.
Zhang Y; Wang R; Fu X; Song H
Diabetol Metab Syndr; 2022 Dec; 14(1):191. PubMed ID: 36528713
[TBL] [Abstract][Full Text] [Related]
26. Comparison of Lipid-Derived Markers for Metabolic Syndrome in Youth: Triglyceride/HDL Cholesterol Ratio, Triglyceride-Glucose Index, and non-HDL Cholesterol.
Lee J; Ah Lee Y; Yong Lee S; Ho Shin C; Hyun Kim J
Tohoku J Exp Med; 2022 Jan; 256(1):53-62. PubMed ID: 35082184
[TBL] [Abstract][Full Text] [Related]
27. Clinical usefulness of lipid ratios, visceral adiposity indicators, and the triglycerides and glucose index as risk markers of insulin resistance.
Du T; Yuan G; Zhang M; Zhou X; Sun X; Yu X
Cardiovasc Diabetol; 2014 Oct; 13():146. PubMed ID: 25326814
[TBL] [Abstract][Full Text] [Related]
28. Altered composition of high density lipoproteins in women with the polycystic ovary syndrome.
Rajkhowa M; Neary RH; Kumpatla P; Game FL; Jones PW; Obhrai MS; Clayton RN
J Clin Endocrinol Metab; 1997 Oct; 82(10):3389-94. PubMed ID: 9329374
[TBL] [Abstract][Full Text] [Related]
29. Correlation between non-insulin-based insulin resistance indexes and the risk of prehypertension: A cross-sectional study.
Zhang X; Yu C; Ye R; Liu T; Chen X
J Clin Hypertens (Greenwich); 2022 May; 24(5):573-581. PubMed ID: 35411676
[TBL] [Abstract][Full Text] [Related]
30. Fasting plasma glucose is a stronger predictor of diabetes than triglyceride-glucose index, triglycerides/high-density lipoprotein cholesterol, and homeostasis model assessment of insulin resistance: Tehran Lipid and Glucose Study.
Tohidi M; Baghbani-Oskouei A; Ahanchi NS; Azizi F; Hadaegh F
Acta Diabetol; 2018 Oct; 55(10):1067-1074. PubMed ID: 30066042
[TBL] [Abstract][Full Text] [Related]
31. Is serum leptin level regulated by thyroid functions, lipid metabolism and insulin resistance in polycystic ovary syndrome?
Erel CT; Senturk LM; Kaleli S; Gezer A; Baysal B; Tasan E
Gynecol Endocrinol; 2003 Jun; 17(3):223-9. PubMed ID: 12857430
[TBL] [Abstract][Full Text] [Related]
32. Triglyceride is a useful surrogate marker for insulin resistance in Korean women with polycystic ovary syndrome.
Park SY; Cho YJ; Lee SR; Chung H; Jeong K
Yonsei Med J; 2015 May; 56(3):785-92. PubMed ID: 25837186
[TBL] [Abstract][Full Text] [Related]
33. The association between hyperuricemia and insulin resistance surrogates, dietary- and lifestyle insulin resistance indices in an Iranian population: MASHAD cohort study.
Seifi N; Nosrati M; Koochackpoor G; Aghasizadeh M; Bahari H; Namdar HB; Afkhami N; Darban RA; Azarian F; Ferns GA; Ghayour-Mobarhan M
Nutr J; 2024 Jan; 23(1):5. PubMed ID: 38172828
[TBL] [Abstract][Full Text] [Related]
34. Are serum chemerin levels different between obese and non-obese polycystic ovary syndrome women?
Yang S; Wang Q; Huang W; Song Y; Feng G; Zhou L; Tan J
Gynecol Endocrinol; 2016; 32(1):38-41. PubMed ID: 26291816
[TBL] [Abstract][Full Text] [Related]
35. Insulin resistance surrogates predict hypertension plus hyperuricemia.
Li Y; You A; Tomlinson B; Yue L; Zhao K; Fan H; Zheng L
J Diabetes Investig; 2021 Nov; 12(11):2046-2053. PubMed ID: 33982885
[TBL] [Abstract][Full Text] [Related]
36. Assessing cardiovascular risk in Mediterranean women with polycystic ovary syndrome.
Rizzo M; Longo RA; Guastella E; Rini GB; Carmina E
J Endocrinol Invest; 2011 Jun; 34(6):422-6. PubMed ID: 20959718
[TBL] [Abstract][Full Text] [Related]
37. Triglyceride glucose index for the detection of asymptomatic coronary artery stenosis in patients with type 2 diabetes.
Thai PV; Tien HA; Van Minh H; Valensi P
Cardiovasc Diabetol; 2020 Sep; 19(1):137. PubMed ID: 32919465
[TBL] [Abstract][Full Text] [Related]
38. The Apolipoprotein B/A1 Ratio is Associated With Metabolic Syndrome Components, Insulin Resistance, Androgen Hormones, and Liver Enzymes in Women With Polycystic Ovary Syndrome.
He H; Feng J; Zhang S; Wang Y; Li J; Gao J; Cong J; Gong Y; Wu X
Front Endocrinol (Lausanne); 2021; 12():773781. PubMed ID: 35069437
[TBL] [Abstract][Full Text] [Related]
39. Dehydroepiandrosterone sulfate/free androgen index ratio predicts a favorable metabolic profile in patients with polycystic ovary syndrome.
Nadir A; Temizkan S; Ozderya A; Temizkan O; Orbay E; Aydin K
Gynecol Endocrinol; 2019 Feb; 35(2):128-132. PubMed ID: 30324855
[TBL] [Abstract][Full Text] [Related]
40. High density lipoprotein-associated proteins in non-obese women with and without polycystic ovary syndrome.
Butler AE; Moin ASM; Reiner Ž; Sathyapalan T; Jamialahmadi T; Sahebkar A; Atkin SL
Front Endocrinol (Lausanne); 2023; 14():1117761. PubMed ID: 37181037
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
